Zobrazeno 1 - 10
of 364
pro vyhledávání: '"Martha GULATI"'
Autor:
Agnes Koczo, MD, Nosheen Reza, MD, Sharonne N. Hayes, MD, Benjamin H. Freed, MD, Martha Gulati, MD MS, Noel Bairey Merz, MD, Kathryn Berlacher, MD MS, Kathryn Sunthankar, MD, Kamala P. Tamirisa, MD
Publikováno v:
JACC: Advances, Vol 3, Iss 10, Pp 101213- (2024)
Externí odkaz:
https://doaj.org/article/c021d15758ef4a2aa0cd5b187bf2a328
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100728- (2024)
Externí odkaz:
https://doaj.org/article/aaf75d7cf4284aaba356e3a2d6964ddf
Autor:
Ashish Kumar, Sourbha Dani, Ajay Sharma, Sumanth Khadke, Martha Gulati, Sanjay Rajagopalan, Sadeer G. Al-Kindi, Sarju Ganatra
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100707- (2024)
Onjective: Climate change and environmental pollution have known health effects. The recently introduced inflation reduction act (IRA) by the United States government includes funding initiatives to curb climate change, and reduce environmental pollu
Externí odkaz:
https://doaj.org/article/712bfb9ecdd34373b27d64c02628b042
Autor:
Anas Hashem, Amani Khalouf, Mohamed Salah Mohamed, Tarek Nayfeh, Ahmed Elkhapery, Salman Zahid, Ahmed Altibi, Harshith Thyagaturu, Anthony Kashou, Nandan S. Anavekar, Martha Gulati, Sudarshan Balla
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e34513- (2024)
Background: Patients with acute heart failure (AHF) exacerbation are susceptible to complications in the setting of COVID-19 infection. Data regarding the racial/ethnic and sex disparities in patients with AHF and COVID-19 remains limited. Objective:
Externí odkaz:
https://doaj.org/article/7e1a34b0e08c43518bcedd31db76267a
Autor:
Aaron J. Walker, Jianhui Zhu, Floyd Thoma, Oscar Marroquin, Amber Makani, Martha Gulati, Eugenia Gianos, Salim S. Virani, Fatima Rodriguez, Steven E. Reis, Christie Ballantyne, Suresh Mulukutla, Anum Saeed
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100664- (2024)
Background: Statins are a cost-effective therapy for prevention of atherosclerotic cardiovascular disease (ASCVD). Guidelines on statins for primary prevention are unclear for older adults (>75 years). Objective: Investigate statin utility in older a
Externí odkaz:
https://doaj.org/article/865c3f4f797c40299c2eb60d1f1c183f
Autor:
Karthik Gonuguntla, Irisha Badu, Sanchit Duhan, Harigopal Sandhyavenu, Muchi Ditah Chobufo, Amro Taha, Harshith Thyagaturu, Yasar Sattar, Bijeta Keisham, Shafaqat Ali, Muhammad Zia Khan, Sharaad Latchana, Minahil Naeem, Ayesha Shaik, Sudarshan Balla, Martha Gulati
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Background The incidence of premature myocardial infarction (PMI) in women (
Externí odkaz:
https://doaj.org/article/5525d84e96e043d0b901186a4c303f7a
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100685- (2024)
Background: The American Heart Association's (AHA) Life's Essential 8 (LE8) score is a helpful tool to quantify cardiovascular health (CVH) metrics. We sought to assess sex differences in relation to LE8 and its components along with association with
Externí odkaz:
https://doaj.org/article/bc4b0e7b95984f3c87ad98ec224d16c2
Autor:
Agnes Koczo, Adipong Brickshawana, Jianhui Zhu, Floyd Thoma, Malamo Countouris, Kathryn Berlacher, Martha Gulati, Erin D Michos, Steven Reis, Suresh Mulukutla, Anum Saeed
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100667- (2024)
Background: In the US, women have similar cardiovascular death rates as men. However, less is known about sex differences in statin use for primary prevention and associated atherosclerotic cardiovascular disease (ASCVD) outcomes. Methods: Statin pre
Externí odkaz:
https://doaj.org/article/a052c4dbbc8d4b43b6e9e17ab5526ac7
Autor:
Frederick Berro Rivera, Linnaeus Louisse A. Cruz, John Vincent Magalong, Jade Monica Marie J. Ruyeras, John Paul Aparece, Nathan Ross B. Bantayan, Kyla Lara-Breitinger, Martha Gulati
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100679- (2024)
Background: Multiple cardiovascular outcomes trials (CVOTs) have shown the efficacy of GLP-1RAs in reducing major adverse cardiovascular events (MACEs) for high-risk patients. However, some CVOTs failed to demonstrate cardiovascular benefits. Objecti
Externí odkaz:
https://doaj.org/article/ddaeeef737334d64a0255d15e73a22cc
Autor:
Carlos Iribarren, Meng Lu, Roberto Elosua, Martha Gulati, Nathan D. Wong, Roger S. Blumenthal, Steven Nissen, Jamal S. Rana
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100661- (2024)
Objective: Many studies support the notion that polygenic risk scores (PRS) improve risk prediction for coronary heart disease (CHD) beyond conventional risk factors. However, PRS are not yet considered risk-enhancing factor in guidelines. Our object
Externí odkaz:
https://doaj.org/article/4d6efadf5cc94724a96e6b32a43ce67f